409 related articles for article (PubMed ID: 22287626)
1. Evolution and function of CAG/polyglutamine repeats in protein-protein interaction networks.
Schaefer MH; Wanker EE; Andrade-Navarro MA
Nucleic Acids Res; 2012 May; 40(10):4273-87. PubMed ID: 22287626
[TBL] [Abstract][Full Text] [Related]
2. Correlation of inter-locus polyglutamine toxicity with CAG•CTG triplet repeat expandability and flanking genomic DNA GC content.
Nestor CE; Monckton DG
PLoS One; 2011; 6(12):e28260. PubMed ID: 22163004
[TBL] [Abstract][Full Text] [Related]
3. Coiled-coil structure-dependent interactions between polyQ proteins and Foxo lead to dendrite pathology and behavioral defects.
Kwon MJ; Han MH; Bagley JA; Hyeon DY; Ko BS; Lee YM; Cha IJ; Kim SY; Kim DY; Kim HM; Hwang D; Lee SB; Jan YN
Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10748-E10757. PubMed ID: 30348793
[TBL] [Abstract][Full Text] [Related]
4. Polyglutamine Repeats in Neurodegenerative Diseases.
Lieberman AP; Shakkottai VG; Albin RL
Annu Rev Pathol; 2019 Jan; 14():1-27. PubMed ID: 30089230
[TBL] [Abstract][Full Text] [Related]
5. Polyglutamine expansion diseases: More than simple repeats.
Silva A; de Almeida AV; Macedo-Ribeiro S
J Struct Biol; 2018 Feb; 201(2):139-154. PubMed ID: 28928079
[TBL] [Abstract][Full Text] [Related]
6. Increased aggregation of polyleucine compared with that of polyglutamine in dentatorubral-pallidoluysian atrophy protein.
Suzuki Y; Jin C; Yazawa I
Neurosci Lett; 2013 Sep; 552():156-61. PubMed ID: 23933208
[TBL] [Abstract][Full Text] [Related]
7. Polyglutamine disease proteins: Commonalities and differences in interaction profiles and pathological effects.
Bonsor M; Ammar O; Schnoegl S; Wanker EE; Silva Ramos E
Proteomics; 2024 Jun; 24(12-13):e2300114. PubMed ID: 38615323
[TBL] [Abstract][Full Text] [Related]
8. Interaction of expanded polyglutamine stretches with nuclear transcription factors leads to aberrant transcriptional regulation in polyglutamine diseases.
Shimohata T; Onodera O; Tsuji S
Neuropathology; 2000 Dec; 20(4):326-33. PubMed ID: 11211059
[TBL] [Abstract][Full Text] [Related]
9. A peptidylic inhibitor for neutralizing expanded
Zhang Q; Chen ZS; An Y; Liu H; Hou Y; Li W; Lau KF; Koon AC; Ngo JCK; Chan HYE
RNA; 2018 Apr; 24(4):486-498. PubMed ID: 29295891
[TBL] [Abstract][Full Text] [Related]
10. The interplay between PolyQ and protein context delays aggregation by forming a reservoir of protofibrils.
Bulone D; Masino L; Thomas DJ; San Biagio PL; Pastore A
PLoS One; 2006 Dec; 1(1):e111. PubMed ID: 17205115
[TBL] [Abstract][Full Text] [Related]
11. The features of polyglutamine regions depend on their evolutionary stability.
Mier P; Andrade-Navarro MA
BMC Evol Biol; 2020 May; 20(1):59. PubMed ID: 32448113
[TBL] [Abstract][Full Text] [Related]
12. Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease.
Adegbuyiro A; Sedighi F; Pilkington AW; Groover S; Legleiter J
Biochemistry; 2017 Mar; 56(9):1199-1217. PubMed ID: 28170216
[TBL] [Abstract][Full Text] [Related]
13. Polyglutamine Repeats in Viruses.
Schein CH
Mol Neurobiol; 2019 May; 56(5):3664-3675. PubMed ID: 30182336
[TBL] [Abstract][Full Text] [Related]
14. Expanded polyglutamine stretches lead to aberrant transcriptional regulation in polyglutamine diseases.
Shimohata T; Onodera O; Tsuji S
Hum Cell; 2001 Mar; 14(1):17-25. PubMed ID: 11436350
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a recruitment and sequestration mechanism in Huntington's disease.
Preisinger E; Jordan BM; Kazantsev A; Housman D
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1029-34. PubMed ID: 10434302
[TBL] [Abstract][Full Text] [Related]
16. CAG Expansions Are Genetically Stable and Form Nontoxic Aggregates in Cells Lacking Endogenous Polyglutamine Proteins.
Zurawel AA; Kabeche R; DiGregorio SE; Deng L; Menon KM; Opalko H; Duennwald ML; Moseley JB; Supattapone S
mBio; 2016 Sep; 7(5):. PubMed ID: 27677791
[TBL] [Abstract][Full Text] [Related]
17. [The Role of Mutant RNA in the Pathogenesis of Huntington's Disease and Other Polyglutamine Diseases].
Bogomazova AN; Eremeev AV; Pozmogova GE; Lagarkova MA
Mol Biol (Mosk); 2019; 53(6):954-967. PubMed ID: 31876275
[TBL] [Abstract][Full Text] [Related]
18. Association of polyalanine and polyglutamine coiled coils mediates expansion disease-related protein aggregation and dysfunction.
Pelassa I; Corà D; Cesano F; Monje FJ; Montarolo PG; Fiumara F
Hum Mol Genet; 2014 Jul; 23(13):3402-20. PubMed ID: 24497578
[TBL] [Abstract][Full Text] [Related]
19. Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset.
Sugaya K; Matsubara S; Kagamihara Y; Kawata A; Hayashi H
PLoS One; 2007 Jul; 2(7):e635. PubMed ID: 17653262
[TBL] [Abstract][Full Text] [Related]
20. Current understanding on the pathogenesis of polyglutamine diseases.
He XH; Lin F; Qin ZH
Neurosci Bull; 2010 Jun; 26(3):247-56. PubMed ID: 20502504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
